$2.5B in outsourcing headed India's way

Subcontinent rising: A new report on India's pharmaceuticals industry predicts it will take over about $2.5 billion in drugmakers' outsourcing by 2012. As companies in the EU and U.S. look for lower-cost manufacturing and R&D, India will get an influx of new work, according to the report from Zinnov Management Consulting.

The country has certainly done a lot to encourage that growth. Besides a rich talent pool and a number of pharma-educational institutes, the Indian government has also started offering tax incentives to drugmakers and set up some necessary legal infrastructure, the report says. "India has the potential to become one of the key global pharmaceutical players and also become the backbone of off-shored services in Pharmaceuticals," Zinnov's CEO said.

- read the story at India Infoline

Suggested Articles

The FDA wants to know what, exactly, is in a drug name—and whether it influences how the product is perceived. So it's launching a study to find out.

Horizon Therapeutics has notched an FDA approval for its rare eye disease med Tepezza (teprotumumab), a possible blockbuster drug in the making.

Eli Lilly has a pipeline stuffed with a host of assets and has decided it needs a new injectable drug and device plant to manufacture some of them.